Browse 341 endocrine clinical trials enrolling across the United States and Canada. Search by city or state to find one near you.
Filter
1
Filter results
Results: 341
Clinical Outcomes Related to Treatment of Distal Symmetric Polyneuropathy Using Semiconductor Embedded Therapeutic Socks
for
Diabetic Neuropathy
Location: Roswell GA
Sponsor: Endocrine Research Solutions
Sex: All
Age: 18 - 70+
Code: NCT06452914
Recruiting
A Study of Changes in Ki67 Expression in People With Breast Cancer Receiving Endocrine Therapy Before Surgery
for
Breast Cancer
Location: New York NY
Sponsor: Memorial Sloan Kettering Cancer Center
Sex: Female
Age: 18+
Code: NCT06127979
Recruiting
Pilot Study of PACHA Program to Enhance Adherence to Adjuvant Endocrine Therapy Among Breast Cancer Survivors
for
Breast Neoplasms, Breast Cancer
Location: Quebec city
Sponsor: CHU de Quebec-Universite Laval
Sex: All
Age: 18+
Code: NCT05887102
Recruiting
Determinants of Acquired Endocrine Resistance in Metastatic Breast Cancer: A Pilot Study
for
Metastatic Breast Cancer
Location: Toronto
Sponsor: Sunnybrook Health Sciences Centre
Sex: All
Age: 18+
Code: NCT04579484
Recruiting
Vitamin D for Prostate Endocrine Therapy
for
Stage I Prostate Cancer AJCC v8,
Location: Newark DE, Scranton PA, Dickson City PA,
Sponsor: University of Rochester
Sex: Male
Age: 50+
Code: NCT05838716
Phase3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence
for
Breast Cancer
Location: South Weymouth MA, Danvers MA, Waltham MA, Boston MA,
Sponsor: Stemline Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT06492616
Phase3, Recruiting
Triage Survey for Cardiovascular, Obesity, and Related Endocrine Trial Eligibility
for
Cardiovascular Diseases, Obesity, PreDiabetes, Diabetes Type 2,
Location: Brooklyn NY
Sponsor: Brooklyn Clinical Research
Sex: All
Age: 18+
Code: NCT06412536
Recruiting
Breast Cancer Endocrine Therapy FITness (BE-FIT) Trial.
for
Breast Neoplasms
Location: Vancouver
Sponsor: University of British Columbia
Sex: Female
Age: 19 - 70+
Code: NCT04824339
Recruiting
A Longitudinal Investigation of the Endocrine and Neurobiologic Events Accompanying Puberty
for
fMRI
Location: Bethesda MD
Sponsor: National Institute of Mental Health (NIMH)
Sex: All
Age: 7 - 35
Code: NCT01434368
Recruiting
Study of GVV858 as a Single Agent or in Combination With Endocrine Therapy in Patients With HR+/HER2- Breast Cancer and Other Advanced Solid Tumors
for
Advanced HR+/HER2- Breast Cancer,
Location: Atlanta GA, Nashville TN, San Antonio TX
Sponsor: Novartis Pharmaceuticals
Sex: All
Age: 18+
Code: NCT07288359
Phase1, Phase2, Recruiting
Endocrine Treatment Alone for Elderly Patients With Estrogen Receptor Positive Operable Breast Cancer and Low Recurrence Score
for
Breast Cancer, Cancer of Breast, Breast Neoplasms,
Location: St Louis MO
Sponsor: Washington University School of Medicine
Sex: Female
Age: 70+
Code: NCT02476786
Phase2, Recruiting
FIH Study of RGT-419B Alone and With Endocrine Therapy in HR-Positive, HER2-Negative Advanced/Metastatic Breast Cancer
for
Breast Cancer
Location: Boston MA, Port Jefferson Station NY, Tampa FL,
Sponsor: Regor Pharmaceuticals Inc.
Sex: All
Age: 18+
Code: NCT05304962
Phase1, Recruiting
Molecular Analyses to Predict Pathways of Endocrine Resistance Following Short Term Neoadjuvant Endocrine Treatment in Patients With Hormone Receptor-Positive HER2-negative Breast Cancer
for
Breast Cancer
Location: Milwaukee WI
Sponsor: Medical College of Wisconsin
Sex: Female
Age: 18+
Code: NCT06361940
Phase2, Recruiting
Metabolic and Endocrine Effects of Repeated Epidural and Sacroiliac Joint Corticosteroid Injections
for
Neck Pain, Back Pain
Location: Winnipeg
Sponsor: University of Manitoba
Sex: All
Age: 18+
Code: NCT01717430
Recruiting
Trial of Pre-operative Neratinib and Endocrine Therapy With Trastuzumab in ER-Positive, HER-2 Positive Breast Cancers
for
Breast Cancer, HER2-positive Breast Cancer,
Location: Hershey PA, Rochester NY, Chicago IL, Madison WI
Sponsor: Ruth O'Regan
Sex: All
Age: 18+
Code: NCT04886531
Phase2, Recruiting
A Study Evaluating the Efficacy and Safety of Inavolisib Plus Fulvestrant Compared With Alpelisib Plus Fulvestrant in Participants With HR-Positive, HER2-Negative, PIK3CA Mutated, Locally Advanced or Metastatic Breast Cancer Post CDK4/6i and Endocrine Combination Therapy
for
Breast Cancer
Location: Boston MA, Atlanta GA
Sponsor: Hoffmann-La Roche
Sex: All
Age: 18+
Code: NCT05646862
Phase3, Recruiting
Supporting Health Including Endocrine Treatment for Long Duration
for
Breast Cancer, Breast Cancer - Female, Breast Carcinoma,
Location: Boston MA
Sponsor: Dana-Farber Cancer Institute
Sex: Female
Age: 18 - 49
Code: NCT07482384
Recruiting
Strategic Endocrine Therapy and Targeted Radiotherapy for Prostate Cancer
for
Prostate Adenocarcinoma
Location: La Jolla CA
Sponsor: University of California, San Diego
Sex: Male
Age: 18+
Code: NCT07364071
Phase2, Recruiting
ERADICATE: A Phase Ib/II Study of Elacestrant Plus Trastuzumab Deruxtecan in Patients With CDK4/6 Inhibitor and Endocrine-resistant HR+/HER2-low or HER2-ultralow Metastatic Breast Cancer
for
Metastatic Breast Cancer, HER2 Low Breast Carcinoma,
Location: Boston MA
Sponsor: Kristina A. Fanucci
Sex: All
Age: 18+
Code: NCT07198724
Phase1, Phase2, Recruiting
Evaluating Dose Timing (Morning vs Evening) of Endocrine-based Therapies in Metastatic Breast and Prostate Cancers
for
Metastatic Breast Cancer, Metastatic Prostate Cancer